% | $
Quotes you view appear here for quick access.

Dynavax Technologies Corporation Message Board

  • outboard.jack outboard.jack Dec 13, 2013 10:08 AM Flag

    Looks like a HOLD

    We only traded 100 Thousand shares in the first 30 Min of trade

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • You do not buy this stock to make money short term. This is a HOLD stock for at least one year. When can you get an opportunity to wait for the new patient study and then get an easy double in share price? Efficacy has never been denied.

      Sentiment: Hold

    • If we can keep holding through December, I think that will make for a great January. IMO

      • 2 Replies to twoishin
      • I agree totally.
        The FDA did not say that Heplisav was unsafe, only that the clinical trials thus far couldn't conclusively prove that the drug was safe. And the company has been scrambling ever since to deliver better data, essentially conducting a completely new Phase III clinical trial. For much of 2013, DVAX has been designing that new trial, and the company recently said that it will get underway in a few months.

        Although that Heplisav trial will not be completed until sometime in 2015, management is likely to deliver interim results throughout 2014, which should serve as catalysts for the stock.

        Meanwhile, Heplisav is also in front of the European Medicines Agency (EMA), and the company is expected to respond to the EMA's final information queries later in the fourth quarter and in early 2014. European approval of Heplisav would quickly push this stock toward the $2.50 to $3 mark, and shares would likely move higher from there as U.S. approval starts to come into focus.

        Sentiment: Hold

      • I don't know for a fact but Grey told us the EMA 120 day letter will be late in Q4,
        Will this POP the Stock don't know, Will it drop the stock I Doubt it.
        Bagged Shorts Might be a nice Gift*

15.83+1.05(+7.10%)3:54 PMEDT